DESMOPRESSIN AC 4 MCG/ML VIAL

What it is

DESMOPRESSIN AC 4 MCG/ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as desmopressin acetate.

FDA gives its dosage form as injection, solution and its route as intravenous; subcutaneous.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Sagent Pharmaceuticals, XGen Pharmaceuticals DJB, Inc. and Fresenius Kabi USA, LLC.

FDA lists it under 2 Established Pharmacologic Classes: Factor VIII Activator and Vasopressin Analog.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $19.15 for 1 mL (1 × $19.14792 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

All 6 NDCs

• 25021-0460-01 · Sagent Pharmaceuticals · $19.14792 per ML · eff. 2026-09-23 filed
• 39822-6200-02 · XGen Pharmaceuticals DJB, Inc. · $19.14792 per ML · eff. 2026-09-23 filed
• 65219-0293-01 · Fresenius Kabi USA, LLC · $19.14792 per ML · eff. 2026-09-23 filed
• 70095-0026-02 · Sun Pharmaceutical Industries, Inc. · $19.14792 per ML · eff. 2026-09-23 filed
• 72485-0523-10 · Armas Pharmaceuticals Inc. · $19.14792 per ML · eff. 2026-09-23 filed
• 83634-0451-01 · Avenacy, LLC · $19.14792 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

4 other products in the NADAC file share the FDA nonproprietary name desmopressin acetate with DESMOPRESSIN AC 4 MCG/ML VIAL.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

What Medicare paid

Medicare Part B’s payment limit for HCPCS J2597, for 2026-10-01 to 2026-12-31, comes to $13.90 for 1 mL, or $13.90 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.695 per 1 MCG.

5 of the product’s 6 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.